• All News
• Consumer
• Pro
• New Drugs
• Pipeline
• Clinical Trials
• FDA Alerts

Hormone-Modulating Therapy May Reduce Dementia Risk in Breast Cancer

Medically reviewed by Carmen Pope, BPharm. Last updated on July 25, 2024.

By Elana Gotkine HealthDay Reporter

THURSDAY, July 25, 2024 -- For women with breast cancer, hormone-modulating therapy (HMT) is associated with reduced risk of Alzheimer disease and related dementias (ADRD), according to a study published online July 16 in JAMA Network Open.

Chao Cai, Ph.D., from the University of South Carolina in Columbia, and colleagues examined the association between HMT for breast cancer treatment and the risk of developing ADRD among women aged 65 years or older in a cohort study.

Of 18,808 women aged 65 years and older diagnosed with breast cancer between 2007 and 2009, 65.7 and 34.3 percent received and did not receive HMT, respectively, within three years after diagnosis. The researchers found that during an average of 12 years of follow-up, 23.7 and 27.9 percent of HMT users and non-HMT users developed ADRD. Overall, HMT was associated with a reduced relative risk of ADRD (hazard ratio [HR], 0.93). The association varied by race and decreased with age. The greatest reduction in ADRD risk associated with HMT was seen for women aged 65 to 74 years who self-identified as Black (HR, 0.76); among women aged 75 years or older, the association was attenuated (HR, 0.81). The relative risk reduction was lower for women aged 65 to 74 years who self-identified as White (HR, 0.89) and was no longer significant for those aged 75 years or older. No significant association was seen for HMT and ADRD for other races.

"Further research is warranted to validate the observed associations in diverse populations and to elucidate the mechanisms underlying our observations," the authors write.

Abstract/Full Text

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2024 HealthDay. All rights reserved.

Posted July 2024

More news resources

• FDA Medwatch Drug Alerts
• Daily MedNews
• News for Health Professionals
• New Drug Approvals
• New Drug Applications
• Drug Shortages
• Clinical Trial Results
• Generic Drug Approvals

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.